Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
24. March 2026
3 min to read

Performance of Artificial Intelligence Powered ECG Analysis in Suspected ST-Segment Elevation Myocardial Infarction

Overview

This study evaluates the real-world performance of an AI-based ECG interpretation tool for detecting STEMI in patients undergoing emergent catheterization laboratory activation, using angiographic findings as the reference standard. Compared with standard clinical ECG interpretation, the AI model achieved higher sensitivity and specificity, significantly reducing false-positive activations while maintaining strong performance even in challenging cases such as arrhythmias or conduction abnormalities. These results suggest that AI-assisted ECG analysis can improve diagnostic accuracy, optimize triage, and support faster, more appropriate decision-making in acute coronary syndrome management.

Published in: JACC Advances
Published on: 23 March 2026

Background

Artificial intelligence (AI)–based electrocardiogram (ECG) analysis has emerged as a promising adjunct to human ECG interpretation in suspected ST-segment elevation myocardial infarction (STEMI).

Methods

Consecutive patients were gathered from a multicenter U.S. STEMI registry (2018-2022) and categorized into 3 clinical cohorts based on the presence or absence of angiographic culprit and troponin elevation: acute myocardial infarction (AMI) with culprit, AMI without culprit, and no-AMI. Cardiac catheterization laboratory-activating ECGs were analyzed using an AI-ECG model trained to identify acute coronary occlusion and classified as occlusion myocardial infarction, OMI(+) or not, OMI(−).

Results

The study included 2,523 patients, 68.3% male, with a median age of 63 years. AMI with culprit was present in 2076 (82.3%), AMI without culprit in 314 (12.4%), and no-AMI in 133 (5.3%). Among AMI with culprit patients, the model correctly identified 93.8% as OMI(+). Sensitivity for TIMI flow 0/1, 2, and 3 was 96.3%, 93.1%, and 86.9%, respectively; P < 0.001. The model correctly identified 79.7% of no-AMI patients as OMI(−). The AUCROC was 0.952 (95% CI: 0.924-0.966). The AMI without culprit cohort included takotsubo syndrome OMI(+) = 78%, MI with nonobstructive coronary arteries OMI(+) = 61%, and myopericarditis OMI(+) = 67%.

Conclusion

In suspected STEMI, this AI-ECG model correctly identified nearly all patients with acute coronary obstruction and most of those without AMI. If prospectively validated, this approach could improve the management of patients with suspected AMI.

Performance of Artificial Intelligence Powered ECG Analysis in Suspected ST-Segment Elevation Myocardial Infarction
Authors: Scott W. Sharkey, Robert Herman, Dawn R. Witt, Frank Aguirre, Mehmet Yildiz, David M. Larson, Avinash Murthy, Heather S. Rohm, Stephen W. Smith, Will Belzer, Jenny Chambers, Ellen Cravero, Seth Bergstedt, Greg Kerola, David Farmer, Andrew Willett, H. Pendell Meyers, Julia Harris, Christopher VanHove, and Timothy D. Henry

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Can an AI ECG algorithm improve diagnostic accuracy for acute coronary occlusion in the difficult subset of canceled catheterization lab activations?

Discordance in ECG interpretation between Emergency Medicine and Cardiology teams is common, and within canceled STEMI activations, a true acute coronary occlusion myocardial infarction (OMI) can go unrecognized. This retrospective study examined whether an AI ECG algorithm (Queen of Hearts™) could improve OMI detection in this difficult subset. Across three referral centers, the investigators analyzed 185 activations canceled for not meeting STEMI criteria, of which 17 met the definition of a missed OMI. The AI algorithm identified 16 of 17 cases, far exceeding STEMI criteria in sensitivity (94.1% vs. 47.1%), supporting its use as an adjunct to clinical judgment in ambiguous cases.

Artificial Intelligence-Assisted, ECG-Based Triage of Patients With Chest Pain to Immediate Invasive Treatment

Rapid identification of acute coronary occlusion (ACO) is critical in chest pain patients, yet conventional STEMI criteria miss occlusion in many NSTEMI cases, delaying life-saving invasive treatment. This retrospective study tested whether a deep learning ECG AI model could improve ACO detection in an unselected cohort of more than 4,000 consecutive patients from a German chest pain unit. Each 12-lead ECG was assessed using both standard STEMI criteria and the AI model, with ACO independently adjudicated by a blinded physician. The AI model clearly outperformed STEMI criteria, identifying 73 of 104 ACO cases versus 30 (area under the curve 0.958 vs. 0.589), with fewer false positives. The findings suggest AI-assisted ECG interpretation can detect subtle ischemic changes beyond established criteria and support faster triage of NSTE-ACO patients to immediate invasive care.

Join over 100,000 healthcare professionals who are already taking advantage of AI